0001209191-19-003805.txt : 20190115 0001209191-19-003805.hdr.sgml : 20190115 20190115185805 ACCESSION NUMBER: 0001209191-19-003805 CONFORMED SUBMISSION TYPE: 3/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190101 FILED AS OF DATE: 20190115 DATE AS OF CHANGE: 20190115 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Holden Stuart CENTRAL INDEX KEY: 0001763999 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38079 FILM NUMBER: 19527918 MAIL ADDRESS: STREET 1: C/O UROGEN PHARMA LTD. STREET 2: 9 HA'TA'ASIYA STREET CITY: RA'ANANA STATE: L3 ZIP: 4365007 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UroGen Pharma Ltd. CENTRAL INDEX KEY: 0001668243 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9 HA'TA'ASIYA ST CITY: RA'ANANA STATE: L3 ZIP: 4365007 BUSINESS PHONE: 972 9 770 7601 MAIL ADDRESS: STREET 1: 9 HA'TA'ASIYA ST CITY: RA'ANANA STATE: L3 ZIP: 4365007 3/A 1 doc3a.xml FORM 3/A SUBMISSION X0206 3/A 2019-01-01 2019-01-10 0 0001668243 UroGen Pharma Ltd. URGN 0001763999 Holden Stuart C/O UROGEN PHARMA LTD. 9 HA?TA?ASIYA STREET RA?ANANA L3 4365007 ISRAEL 1 0 0 0 Stock Option (right to buy) 5.94 2022-12-10 Ordinary Shares 48000 D 33.33% of the shares underlying the stock option vested on each of December 10, 2016, December 10, 2017 and December 10, 2018. This option grant was inadvertently omitted from the Reporting Person's initial Form 3. /s/ Peter Pfreundschuh, Attorney-in-Fact 2019-01-15